![Angelica Loskog](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Angelica Loskog
Direttore/Membro del Consiglio presso
MEDIVIR AB
Patrimonio netto: 1 286 $ in data 31/08/2026
Profilo
Angelica Loskog currently works at Lokon Pharma AB, as Chief Executive Officer & Director, Repos Pharma AB, as Chairman, Medivir AB, as Director from 2024, the University of Uppsala, as Associate Professor, and Nexttobe AB, as Scientific Adviser.
Dr. Loskog also formerly worked at Vivolux AB, as Chairman, Hansa Biopharma AB, as Independent Director from 2016 to 2019, and Bioimics AB, as Director.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/03/2026 | 6.309 ( 0% ) | 1 286 $ | 31/08/2026 |
Posizioni attive di Angelica Loskog
| Società | Posizione | Inizio |
|---|---|---|
| MEDIVIR AB | Direttore/Membro del Consiglio | 01/01/2024 |
Nexttobe AB
 Nexttobe AB Investment ManagersFinance Acts as an alternative investment manager | Direttore Tecnico/Scientifico/R&S | - |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Lokon Pharma AB
 Lokon Pharma AB Miscellaneous Commercial ServicesCommercial Services Provides immunostimulatory gene therapy services | Amministratore Delegato | - |
Repos Pharma AB | Presidente | - |
Precedenti posizioni note di Angelica Loskog
| Società | Posizione | Fine |
|---|---|---|
| HANSA BIOPHARMA AB | Direttore/Membro del Consiglio | 22/05/2019 |
Bioimics AB | Direttore/Membro del Consiglio | - |
Vivolux AB
 Vivolux AB BiotechnologyHealth Technology Develops biotechnology for anticancer drugs | Presidente | - |
Formazione di Angelica Loskog
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
75
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Medivir AB
 Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansa Biopharma AB
 Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Vivolux AB
Vivolux AB BiotechnologyHealth Technology Develops biotechnology for anticancer drugs | Health Technology |
Nexttobe AB
Nexttobe AB Investment ManagersFinance Acts as an alternative investment manager | Finance |
Bioimics AB | |
Lokon Pharma AB
Lokon Pharma AB Miscellaneous Commercial ServicesCommercial Services Provides immunostimulatory gene therapy services | Commercial Services |
Repos Pharma AB |
